Maple Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$728K Buy
3,922
+493
+14% +$91.5K 0.05% 65
2025
Q1
$718K Buy
3,429
+1,092
+47% +$229K 0.06% 65
2024
Q4
$415K Buy
2,337
+497
+27% +$88.3K 0.03% 83
2024
Q3
$363K Sell
1,840
-225
-11% -$44.4K 0.03% 87
2024
Q2
$354K Buy
2,065
+5
+0.2% +$858 0.03% 92
2024
Q1
$375K Sell
2,060
-107
-5% -$19.5K 0.03% 82
2023
Q4
$336K Buy
2,167
+805
+59% +$125K 0.03% 79
2023
Q3
$203K Buy
+1,362
New +$203K 0.02% 94
2023
Q1
Sell
-1,284
Closed -$208K 98
2022
Q4
$208K Sell
1,284
-77
-6% -$12.4K 0.03% 92
2022
Q3
$207K Buy
+1,361
New +$207K 0.03% 89
2022
Q2
Sell
-1,361
Closed -$221K 92
2022
Q1
$221K Buy
+1,361
New +$221K 0.03% 95
2015
Q4
Sell
-84,817
Closed -$4.62M 127
2015
Q3
$4.62M Sell
84,817
-2,960
-3% -$161K 1.71% 23
2015
Q2
$5.9M Sell
87,777
-1,449
-2% -$97.4K 2.02% 18
2015
Q1
$5.22M Buy
89,226
+43,828
+97% +$2.57M 1.82% 22
2014
Q4
$2.97M Buy
45,398
+1,048
+2% +$68.6K 1.08% 38
2014
Q3
$2.56M Sell
44,350
-1,125
-2% -$65K 0.97% 40
2014
Q2
$2.57M Sell
45,475
-710
-2% -$40.1K 0.93% 44
2014
Q1
$2.37M Sell
46,185
-1,303
-3% -$67K 0.92% 44
2013
Q4
$2.51M Sell
47,488
-500
-1% -$26.4K 1% 40
2013
Q3
$2.15M Sell
47,988
-2,930
-6% -$131K 0.95% 41
2013
Q2
$2.11M Buy
+50,918
New +$2.11M 0.94% 43